Skip to content

Advertisement

  • Editorial
  • Open Access

Endorsement of International Consensus Radiochemistry Nomenclature Guidelines

  • 1Email author,
  • 2,
  • 3, 4,
  • 5,
  • 6 and
  • 7
European Journal of Hybrid ImagingEJNMMI Multimodality Journal20193:6

https://doi.org/10.1186/s41824-018-0048-9

  • Received: 8 November 2018
  • Accepted: 8 November 2018
  • Published:

The Related Article to this article has been published.

With the open letter published in EJNMMI Radiopharmacy and Chemistry by an international working group of experts, the EJNMMI journal family endorses the application of the guidelines in contributions to the journals.

Attached to the letter by the working group is a three-page summary highlighting the most relevant issues used in the notation of radiopharmaceuticals and related terms.

The full paper with all recommendations is published in “Consensus nomenclature rules for radiopharmaceutical chemistry—setting the record straight, Coenen, H.H., Gee A.D. et al., Nuclear Medicine and Biology, Volume 55, v–xi (2017)” (https://doi.org/10.1016/j.nucmedbio.2017.09.004).

All Editors-in-Chief of the EJNMMI journals strongly recommend all manuscripts meet these guidelines upon submission. In addition, all reviewers will be asked to be aware of the guidelines and wherever possible to check if the guidelines are followed.

Editors-in-Chief,

Philip Elsinga

Angelika Bischof Delaloye

Arturo Chiti

Stefaan Vandenberghe

Francesco Giammarile

Ignasi Carrio

Notes

Declarations

Authors’ contributions

All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

(1)
Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 EZ Groningen, The Netherlands
(2)
Nuclear Medicine Service, Centre Hospitalier Universitaire Vaudois, Bugnon 46, 1011 Lausanne, Switzerland
(3)
Department of Biomedical Sciences, Humanitas University, Milan, Italy
(4)
Department of Diagnostic Imaging, Humanitas Clinical and Research Center - IRCCS, Milan, Italy
(5)
MEDISIP-ELIS-IBITECH, Ghent University, Corneel Heymanslaan, 10 9000 Ghent, Belgium
(6)
Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, International Atomic Energy Agency, Vienna, Austria
(7)
Department of Radiology and Medical Physics, Hospital de Sant Pau, Barcelona, Spain

Copyright

© The Author(s) 2019

Advertisement